World leader in gases, technologies and services for Industry and Health, Air Liquide is present in 80 countries with close to 50,000 employees and serves more than 2 million customers and patients. Oxygen, nitrogen and hydrogen have been at the core of the company’s activities since its creation in 1902. Air Liquide’s ambition is to be the leader in its industry, delivering long-term performance and acting responsibly.
Air Liquide ideas create value over the long term. At the core of the company’s development are the commitment and constant inventiveness of its people. Air Liquide anticipates the challenges of its markets, invests locally and globally, and delivers high-quality solutions to its customers and patients, and the scientific community.
The company relies on competitiveness in its operations, targeted investments in growing markets and innovation to deliver profitable growth over the long-term.
To feed its appetite for innovation, Air Liquide relies on 1 000 researchers of 35 nationalities. Its global R&D network is based on 10 R&D hubs spread over 3 continents (Europe, America and Asia) for a customer oriented research.
Air Liquide address multiple sectors and is already a supplier for ferrous and non-ferrous primary metals market. The Company offers a broad range of solutions that help industrials to reach their objectives. Air Liquide's solution ensures fuel savings, a capacity increase, a high metallic yield, high quality products and a clean environment.
The objective of our participation in this project is to continue research and development around a new bioleaching concept using oxygen. This new concept, developed with partners BRGM and Milton Roy Mixing, will allow a reduced CAPEX while ensuring good performance.